Results 51 to 60 of about 18,650 (251)

A survey on utilization of data mining approaches for dermatological (skin) diseases prediction [PDF]

open access: yes, 2011
Due to recent technology advances, large volumes of medical data is obtained. These data contain valuable information. Therefore data mining techniques can be used to extract useful patterns.
Adibi, N   +4 more
core  

Revisions of Theophanes Chrysobalantes De Curatione [version 2; referees: 4 approved] [PDF]

open access: yes, 2017
Background: Theophanes Chrysobalantes' De curatione is a little known but highly relevant therapeutic manual dating to the tenth century AD. The text has come down to us in  an unusually large number of manuscripts, most of which transmit a mainstream ...
Zipser, Barbara
core   +2 more sources

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk

open access: yesBritish Journal of Haematology, EarlyView.
Inherited thrombocytopenia (IT) caused by germline variants in RUNX1, ETV6 or ANKRD26 carries a high risk of developing haematological malignancy. This study examined the clinical, platelet and molecular characteristics of 66 patients with these conditions, who carried 24 distinct genetic variants in the corresponding genes.
Ana Marín‐Quílez   +34 more
wiley   +1 more source

The diagnosis of early‐stage mycosis fungoides: Views held by experts and non‐experts in cutaneous lymphoma

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Mycosis fungoides (MF) accounts for the majority of cutaneous lymphomas (CL). There is a documented delay in the diagnosis of early‐stage MF. However, its timely diagnosis is paramount to avoid potentially harmful therapies and undue patient distress.
Paula Beatty   +7 more
wiley   +1 more source

PITYRIASIS NIGRA. [PDF]

open access: yesThe Lancet
n ...
openaire   +1 more source

Acral pityriasis rosea: A rare variant of pityriasis rosea

open access: yesDermatology Reports, 2021
Pityriasis rosea (PR) is a common, selflimited inflammatory skin condition, usually affects the trunk and proximal extremities. A variety of atypical manifestations of PR have been recognized ranging from the difference in the morphology, distribution, and course.
Pimpa Tantanasrigul   +2 more
openaire   +4 more sources

Novos aspectos na evolução clínica da pitiríase versicolor New aspects in the clinical course of pityriasis versicolor

open access: yesAnais Brasileiros de Dermatologia, 2011
FUNDAMENTO: A pitiríase versicolor é uma doença infecciosa causada por várias espécies de Malassezia com uma tendência a se tornar recidivante ou crônica.
Valéria Maria de Souza Framil   +3 more
doaj   +1 more source

Reflectance confocal microscopy for the diagnosis of skin infections and infestations [PDF]

open access: yes, 2020
Reflectance confocal microscopy (RCM) is a noninvasive real-time imaging technique that has been widely used for the diagnosis of skin cancer. More recently, it has been reported as a useful tool for the diagnosis and management of several inflammatory ...
Arzberger, Edith   +6 more
core  

Domperidone‐induced pityriasis rosea‐like drug eruption

open access: yesClinical Case Reports, 2022
Pityriasis rosea is a common, acute, self limiting inflammatory skin disease. Pityriasis rosea‐like eruptions (PR‐LE) have been reported after drugs. The clinical presentation of PR‐LE can be distinguished from pityriasis rosea.
Sarra Saad   +3 more
doaj   +1 more source

Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This cohort study of 1793 atopic dermatitis patients (aged ≥ 12) found higher infection rates with Janus kinase inhibitor treatment compared to biologic treatment, particularly for herpes infections, with a history of viral or fungal skin infection as a risk factor associated with infection.
Lian F. van der Gang   +22 more
wiley   +1 more source

Home - About - Disclaimer - Privacy